Adverse Drug Reaction Classification System

ADR Ontology
ADR Term Cushingoid
ADR ID BADD_A01131
ADR Hierarchy
05      Endocrine disorders
05.01      Adrenal gland disorders
05.01.01      Adrenal cortical hyperfunctions
05.01.01.002      Cushingoid
14      Metabolism and nutrition disorders
14.11      Metabolism disorders NEC
14.11.01      Metabolic disorders NEC
14.11.01.006      Cushingoid
19      Psychiatric disorders
19.07      Psychiatric disorders NEC
19.07.03      Mental disorders due to a general medical condition NEC
19.07.03.001      Cushingoid
24      Vascular disorders
24.08      Vascular hypertensive disorders
24.08.02      Vascular hypertensive disorders NEC
24.08.02.004      Cushingoid
Description A disorder characterized by signs and symptoms that resemble Cushing's disease or syndrome: buffalo hump obesity, striations, adiposity, hypertension, diabetes, and osteoporosis, usually due to exogenous corticosteroids. [CTCAE]
MedDRA Code 10011655
MeSH ID Not Available
ADR Severity Grade (FAERS)
ADR Severity Grade (CTCAE)
Synonym
Cushing-like build | Cushingoid | Cushingoid facies | Moon face | Moon face top
ADR Related Proteins
Protein Name UniProt AC TTD Target ID
Not AvailableNot AvailableNot Available
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D01436Methylprednisolone sodium succinate--
BADD_D01496Montelukast0.000069%
BADD_D01831Prednisolone--
BADD_D01832Prednisolone acetate--
BADD_D01833Prednisolone sodium phosphate--
BADD_D01834Prednisone0.000378%
BADD_D01952Ritonavir0.003367%
BADD_D02192Thalidomide0.001158%
BADD_D02236Tofacitinib--
BADD_D02270Tretinoin--
BADD_D02271Triamcinolone--
BADD_D02272Triamcinolone acetonide--
BADD_D02273Triamcinolone diacetate--
BADD_D02274Triamcinolone hexacetonide--
BADD_D02492Deflazacort0.002732%
The 2th Page    First    Pre   2    Total 2 Pages